Good morning to all fellow CYP investors.
We are all I guess, impatient for success. I worked in the pharma business for many many years. The average time for a new drug or procedure from inception to medical approval and use is generally measured in 10 to 15 years and costs that go into the stratosphere.
Much of that time is spent going through the mill that is clinical trials.
For us here on HC the situation is slightly different. Our interest isn't so much the time it will take to get the product to the market place, as the time it will take for the financial markets to become interested in the product. Given that we have already started phase 1 trials and indeed had some safety and efficacy data we are well along that road.
So I would say that some patience is required, but maybe not too much. Assuming the next part of the current trials goes according to plan, the results will be published and the world will take note.
So on that basis we are talking about maybe a few months, certainly no more than a year.
Courage mon braves - softly softly catchee monkee. All is in place
- Forums
- ASX - By Stock
- We are close
Good morning to all fellow CYP investors. We are all I guess,...
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
|
|||||
Last
21.0¢ |
Change
-0.005(2.33%) |
Mkt cap ! $37.91M |
Open | High | Low | Value | Volume |
21.0¢ | 21.0¢ | 20.5¢ | $11.26K | 53.68K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 7339 | 20.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
22.5¢ | 32225 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 7339 | 0.205 |
3 | 131303 | 0.200 |
2 | 68825 | 0.195 |
3 | 122713 | 0.190 |
3 | 15055 | 0.180 |
Price($) | Vol. | No. |
---|---|---|
0.225 | 32225 | 2 |
0.230 | 161397 | 3 |
0.240 | 10000 | 1 |
0.255 | 187726 | 1 |
0.270 | 30000 | 1 |
Last trade - 15.39pm 23/08/2024 (20 minute delay) ? |
CYP (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online